Sreelatha Meleth, Ph.D.
Affiliations: | 2001 | The University of Alabama, Tuscaloosa, AL |
Area:
StatisticsGoogle:
"Sreelatha Meleth"Parents
Sign in to add mentor| James D. Leeper | grad student | 2001 | University of Alabama | |
| (Analyzing data sets with a mixture of MAR and NINR missing data: Assessing the impact of sample size and proportion missing on the estimates.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Katkoori VR, Suarez-Cuervo C, Shanmugam C, et al. (2010) Bax expression is a candidate prognostic and predictive marker of colorectal cancer. Journal of Gastrointestinal Oncology. 1: 76-89 |
| Nabors LB, Fiveash JB, Markert JM, et al. (2010) A phase 1 trial of ABT-510 concurrent with standard chemoradiation for patients with newly diagnosed glioblastoma. Archives of Neurology. 67: 313-9 |
| Shah AC, Parker JN, Gillespie GY, et al. (2007) Enhanced antiglioma activity of chimeric HCMV/HSV-1 oncolytic viruses. Gene Therapy. 14: 1045-54 |
| Guffey MB, Parker JN, Luckett WS, et al. (2007) Engineered herpes simplex virus expressing bacterial cytosine deaminase for experimental therapy of brain tumors. Cancer Gene Therapy. 14: 45-56 |
| Shah AC, Price KH, Parker JN, et al. (2006) Serial passage through human glioma xenografts selects for a Deltagamma134.5 herpes simplex virus type 1 mutant that exhibits decreased neurotoxicity and prolongs survival of mice with experimental brain tumors. Journal of Virology. 80: 7308-15 |
| Falkenberg E, Kim RY, Meleth S, et al. (2006) Low-dose-rate vs. high-dose-rate intracavitary brachytherapy for carcinoma of the cervix: The University of Alabama at Birmingham (UAB) experience. Brachytherapy. 5: 49-55 |
| Manne U, Suarez-Cuervo C, Jhala NC, et al. (2006) Phenotypic expression of Bax is a predictive marker of 5-fluorouracil treatment in colorectal cancer Journal of Clinical Oncology. 24: 3605-3605 |
| Chatla C, Jhala NC, Katkoori VR, et al. (2005) Recurrence and survival predictive value of phenotypic expression of Bcl-2 varies with tumor stage of colorectal adenocarcinoma. Cancer Biomarkers : Section a of Disease Markers. 1: 241-50 |
| Mahendra G, Kumar S, Isayeva T, et al. (2005) Antiangiogenic cancer gene therapy by adeno-associated virus 2-mediated stable expression of the soluble FMS-like tyrosine kinase-1 receptor. Cancer Gene Therapy. 12: 26-34 |
| Manne U, Jhala NC, Jones J, et al. (2004) Prognostic significance of p27(kip-1) expression in colorectal adenocarcinomas is associated with tumor stage. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 1743-52 |